Capital Gains Report, a firm providing research for micro-cap investors, continues its series on companies positioned to help combat inflation. Traditionally, there are 7 sectors that perform well under inflationary conditions; Real Estate, Energy, Bonds, Financial Companies, Commodities, Consumer Staples, and Healthcare. Each industry contains several oversold opportunities for investors, today we are highlighting a healthcare play, Wearable Health Solutions, Inc. (OTCMKTS: WHSI).Wearable Health Solutions, Inc. is a medical device company that touches several lucrative healthcare segments with its suite of products. The company has experienced tremendous growth recently, and there is reason to believe this will continue or maybe even accelerate.
Reasons WHSI Set to Soar
Wearable Health Solutions, Inc. (OTCMKTS: WHSI) is a manufacturer of next-generation personal medical alarms and safety alert devices. WHSI’s technology can provide a leading edge for the Company in our current cutting-edge technology-driven markets.
Only Publicly Traded Small Cap Stock in the $7.4 Billion PERS Market–Wall Street Research predicts the total addressable opportunity in this market to reach 19-24% by 2030
iHelp Max 4G Release
WHSI’s iHelp MAX™ 4G device is reportedly launching this year. The device will do more than transmit an emergency alarm for the user. It will also send medical personnel vital signs, such as heart rate. This next-generation release would be huge for WHSI stock.
Major Marketing Campaign Kickoff Imminent
WHSI is launching a worldwide marketing campaign to expand its international network of distributors. Production is underway for the company’s spots on the weekly ‘Worldwide Business With kathy ireland®” show. Ireland’s Company Reaches Over 200+ Million Households broadcast on FOX Business Network, Bloomberg International Television and video streams on all major social media platforms.
WHSI Up Listing
WHSI’s Mark Cayle recently commented after releasing its Form 10, “Once our Form 10 Registration Statement is effective, we will consider an up listing to a broader stock exchange which could expand our exposure to institutional investors, money managers, family office funds, broker dealers, and other investors which is an important milestone in our corporate progression,” he concluded. An uplisting would be a major catalytic event. Here’s why: When a company uplists from the pink sheets it provides investors the peace of mind that comes with increased regulation, transparency and disclosure. This can translate to:
- Lower Cost of Capital–that can in turn accelerate the company’s growth and increase margins.
- Analyst Coverage– uplisting allows analysts to cover the stock and this is important because analyst coverage can lead to:
- Institutional Investment
- High-Net-Worth Individual Investors
- Increased Liquidity and Valuation– all of the above factors can lead to increased interest in the stock on all levels, and this influx of interest can be a force multiplier.
WHSI Business is Thriving Despite Market Conditions
For the fiscal year ending June 30th, 2021, WHSI reported some 8,000 end users plus an order book of about 2,000+ potential activations, which earned the company record revenues ($1.3 million) in 2021.
Launching its new device could lead to a consecutive year of record sales.
WHSI’s Market Opportunity
Currently, WHSI competes in: –The $23.3 billion remote patient operating market (RPM). Research firm MarketsAndMarkets projects this market will grow at a CAGR of 38.2% to reach $117 billion by 2025.
–The giant mobile health (mHealth) market which is forecast to reach $166.2 billion by 2028, according to GrandViewResearch.
–And is the only micro-cap opportunity in the $4 billion personal emergency response market. MarketDataForecast forecasts that the (PERS) market will grow from $4.09 billion in 2021 to $5.29 billion globally by the end of 2026. That represents CAGR growth of 5.3%.
WHSI is a multiple revenue stream company. WHSI forecasts that its sales could reach $5.87 million in 2022. In the nine month period ended March 31, 2021, total revenues were $1.03 million. It represents a 37% jump from $757,000 for the comparable period in 2020. For the first nine months of this fiscal year, WHSI reported $488,000 in gross profit, or 47.1% of total revenues. That is very impressive for a stock trading where WHSI is currently.
WHSI’s Competitive Advantage
WHSI appears to be the only publicly traded micro-cap pure-play in the PERS industry. Most of WHSI’s competition sells directly to end users, but WHSI’s business plan is different in that they primarily are selling to dealers, which not only creates recurring revenue but also calls for substantially less overhead.
WHSI provides investors an opportunity in an industry that traditionally performs well under inflationary conditions. The company has several potential catalysts ahead in 2022 that could send the stock soaring. Make sure to start your research today.
Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. Capital Gains Report ‘CGR’ is responsible for the production and distribution of this content. CGR is not operated by a licensed broker, a dealer, or a registered investment adviser. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. CGR authors, contributors, or its agents, may be compensated for preparing research, video graphics, and editorial content. CGR has been compensated three thousand dollars via wire transfer by Wearable Health Solutions, Inc. to produce and syndicate content for WHSI. As part of that content, readers, subscribers, and website viewers, are expected to read the full disclaimers and financial disclosures statement that can be found on our website.